nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Confusional state—Capecitabine—prostate cancer	0.000263	0.000263	CcSEcCtD
Meropenem—Tachycardia—Docetaxel—prostate cancer	0.000263	0.000263	CcSEcCtD
Meropenem—Headache—Estradiol—prostate cancer	0.000262	0.000262	CcSEcCtD
Meropenem—Skin disorder—Docetaxel—prostate cancer	0.000261	0.000261	CcSEcCtD
Meropenem—Agitation—Prednisone—prostate cancer	0.000261	0.000261	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000261	0.000261	CcSEcCtD
Meropenem—Oedema—Capecitabine—prostate cancer	0.00026	0.00026	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—prostate cancer	0.00026	0.00026	CcSEcCtD
Meropenem—Angioedema—Prednisone—prostate cancer	0.00026	0.00026	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—prostate cancer	0.000259	0.000259	CcSEcCtD
Meropenem—Infection—Capecitabine—prostate cancer	0.000259	0.000259	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000258	0.000258	CcSEcCtD
Meropenem—Urticaria—Etoposide—prostate cancer	0.000257	0.000257	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—prostate cancer	0.000257	0.000257	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—prostate cancer	0.000257	0.000257	CcSEcCtD
Meropenem—Anorexia—Docetaxel—prostate cancer	0.000256	0.000256	CcSEcCtD
Meropenem—Malaise—Prednisone—prostate cancer	0.000256	0.000256	CcSEcCtD
Meropenem—Shock—Capecitabine—prostate cancer	0.000256	0.000256	CcSEcCtD
Meropenem—Body temperature increased—Etoposide—prostate cancer	0.000256	0.000256	CcSEcCtD
Meropenem—Abdominal pain—Etoposide—prostate cancer	0.000256	0.000256	CcSEcCtD
Meropenem—Nervous system disorder—Capecitabine—prostate cancer	0.000255	0.000255	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—prostate cancer	0.000255	0.000255	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—prostate cancer	0.000255	0.000255	CcSEcCtD
Meropenem—Thrombocytopenia—Capecitabine—prostate cancer	0.000255	0.000255	CcSEcCtD
Meropenem—Syncope—Prednisone—prostate cancer	0.000255	0.000255	CcSEcCtD
Meropenem—Tachycardia—Capecitabine—prostate cancer	0.000254	0.000254	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—prostate cancer	0.000253	0.000253	CcSEcCtD
Meropenem—Skin disorder—Capecitabine—prostate cancer	0.000253	0.000253	CcSEcCtD
Meropenem—Sweating—Doxorubicin—prostate cancer	0.000252	0.000252	CcSEcCtD
Meropenem—Hyperhidrosis—Capecitabine—prostate cancer	0.000252	0.000252	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—prostate cancer	0.000252	0.000252	CcSEcCtD
Meropenem—Hypotension—Docetaxel—prostate cancer	0.000251	0.000251	CcSEcCtD
Meropenem—Loss of consciousness—Prednisone—prostate cancer	0.00025	0.00025	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000249	0.000249	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—prostate cancer	0.000248	0.000248	CcSEcCtD
Meropenem—Anorexia—Capecitabine—prostate cancer	0.000248	0.000248	CcSEcCtD
Meropenem—Nausea—Estradiol—prostate cancer	0.000248	0.000248	CcSEcCtD
Meropenem—Vomiting—Mitoxantrone—prostate cancer	0.000247	0.000247	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—prostate cancer	0.000246	0.000246	CcSEcCtD
Meropenem—Hypertension—Prednisone—prostate cancer	0.000245	0.000245	CcSEcCtD
Meropenem—Rash—Mitoxantrone—prostate cancer	0.000245	0.000245	CcSEcCtD
Meropenem—Dermatitis—Mitoxantrone—prostate cancer	0.000245	0.000245	CcSEcCtD
Meropenem—Headache—Mitoxantrone—prostate cancer	0.000244	0.000244	CcSEcCtD
Meropenem—Hypotension—Capecitabine—prostate cancer	0.000243	0.000243	CcSEcCtD
Meropenem—Insomnia—Docetaxel—prostate cancer	0.000243	0.000243	CcSEcCtD
Meropenem—Paraesthesia—Docetaxel—prostate cancer	0.000242	0.000242	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—prostate cancer	0.000241	0.000241	CcSEcCtD
Meropenem—Anxiety—Prednisone—prostate cancer	0.000241	0.000241	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—prostate cancer	0.000241	0.000241	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00024	0.00024	CcSEcCtD
Meropenem—Dyspnoea—Docetaxel—prostate cancer	0.00024	0.00024	CcSEcCtD
Meropenem—Somnolence—Docetaxel—prostate cancer	0.000239	0.000239	CcSEcCtD
Meropenem—Hypersensitivity—Etoposide—prostate cancer	0.000238	0.000238	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—prostate cancer	0.000238	0.000238	CcSEcCtD
Meropenem—Dyspepsia—Docetaxel—prostate cancer	0.000237	0.000237	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—prostate cancer	0.000236	0.000236	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—prostate cancer	0.000236	0.000236	CcSEcCtD
Meropenem—Insomnia—Capecitabine—prostate cancer	0.000236	0.000236	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—prostate cancer	0.000235	0.000235	CcSEcCtD
Meropenem—Paraesthesia—Capecitabine—prostate cancer	0.000234	0.000234	CcSEcCtD
Meropenem—Decreased appetite—Docetaxel—prostate cancer	0.000234	0.000234	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—prostate cancer	0.000233	0.000233	CcSEcCtD
Meropenem—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000232	0.000232	CcSEcCtD
Meropenem—Asthenia—Etoposide—prostate cancer	0.000232	0.000232	CcSEcCtD
Meropenem—Dyspnoea—Capecitabine—prostate cancer	0.000232	0.000232	CcSEcCtD
Meropenem—Anaphylactic shock—Prednisone—prostate cancer	0.000232	0.000232	CcSEcCtD
Meropenem—Oedema—Prednisone—prostate cancer	0.000232	0.000232	CcSEcCtD
Meropenem—Nausea—Mitoxantrone—prostate cancer	0.000231	0.000231	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—prostate cancer	0.000231	0.000231	CcSEcCtD
Meropenem—Infection—Prednisone—prostate cancer	0.00023	0.00023	CcSEcCtD
Meropenem—Pain—Docetaxel—prostate cancer	0.00023	0.00023	CcSEcCtD
Meropenem—Constipation—Docetaxel—prostate cancer	0.00023	0.00023	CcSEcCtD
Meropenem—Dyspepsia—Capecitabine—prostate cancer	0.000229	0.000229	CcSEcCtD
Meropenem—Chills—Epirubicin—prostate cancer	0.000229	0.000229	CcSEcCtD
Meropenem—Pruritus—Etoposide—prostate cancer	0.000229	0.000229	CcSEcCtD
Meropenem—Shock—Prednisone—prostate cancer	0.000228	0.000228	CcSEcCtD
Meropenem—Nervous system disorder—Prednisone—prostate cancer	0.000228	0.000228	CcSEcCtD
Meropenem—Tachycardia—Prednisone—prostate cancer	0.000226	0.000226	CcSEcCtD
Meropenem—Decreased appetite—Capecitabine—prostate cancer	0.000226	0.000226	CcSEcCtD
Meropenem—Skin disorder—Prednisone—prostate cancer	0.000225	0.000225	CcSEcCtD
Meropenem—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000225	0.000225	CcSEcCtD
Meropenem—Hyperhidrosis—Prednisone—prostate cancer	0.000224	0.000224	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—prostate cancer	0.000223	0.000223	CcSEcCtD
Meropenem—Constipation—Capecitabine—prostate cancer	0.000223	0.000223	CcSEcCtD
Meropenem—Pain—Capecitabine—prostate cancer	0.000223	0.000223	CcSEcCtD
Meropenem—Erythema—Epirubicin—prostate cancer	0.000222	0.000222	CcSEcCtD
Meropenem—Feeling abnormal—Docetaxel—prostate cancer	0.000222	0.000222	CcSEcCtD
Meropenem—Diarrhoea—Etoposide—prostate cancer	0.000221	0.000221	CcSEcCtD
Meropenem—Anorexia—Prednisone—prostate cancer	0.000221	0.000221	CcSEcCtD
Meropenem—Gastrointestinal pain—Docetaxel—prostate cancer	0.00022	0.00022	CcSEcCtD
Meropenem—Flatulence—Epirubicin—prostate cancer	0.000219	0.000219	CcSEcCtD
Meropenem—Tension—Epirubicin—prostate cancer	0.000218	0.000218	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—prostate cancer	0.000218	0.000218	CcSEcCtD
Meropenem—Nervousness—Epirubicin—prostate cancer	0.000216	0.000216	CcSEcCtD
Meropenem—Back pain—Epirubicin—prostate cancer	0.000215	0.000215	CcSEcCtD
Meropenem—Feeling abnormal—Capecitabine—prostate cancer	0.000215	0.000215	CcSEcCtD
Meropenem—Dizziness—Etoposide—prostate cancer	0.000214	0.000214	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—prostate cancer	0.000213	0.000213	CcSEcCtD
Meropenem—Gastrointestinal pain—Capecitabine—prostate cancer	0.000213	0.000213	CcSEcCtD
Meropenem—Abdominal pain—Docetaxel—prostate cancer	0.000213	0.000213	CcSEcCtD
Meropenem—Body temperature increased—Docetaxel—prostate cancer	0.000213	0.000213	CcSEcCtD
Meropenem—Chills—Doxorubicin—prostate cancer	0.000212	0.000212	CcSEcCtD
Meropenem—Insomnia—Prednisone—prostate cancer	0.00021	0.00021	CcSEcCtD
Meropenem—Paraesthesia—Prednisone—prostate cancer	0.000208	0.000208	CcSEcCtD
Meropenem—Urticaria—Capecitabine—prostate cancer	0.000207	0.000207	CcSEcCtD
Meropenem—Body temperature increased—Capecitabine—prostate cancer	0.000206	0.000206	CcSEcCtD
Meropenem—Abdominal pain—Capecitabine—prostate cancer	0.000206	0.000206	CcSEcCtD
Meropenem—Vomiting—Etoposide—prostate cancer	0.000206	0.000206	CcSEcCtD
Meropenem—Erythema—Doxorubicin—prostate cancer	0.000206	0.000206	CcSEcCtD
Meropenem—Anaemia—Epirubicin—prostate cancer	0.000205	0.000205	CcSEcCtD
Meropenem—Agitation—Epirubicin—prostate cancer	0.000204	0.000204	CcSEcCtD
Meropenem—Dyspepsia—Prednisone—prostate cancer	0.000204	0.000204	CcSEcCtD
Meropenem—Rash—Etoposide—prostate cancer	0.000204	0.000204	CcSEcCtD
Meropenem—Dermatitis—Etoposide—prostate cancer	0.000204	0.000204	CcSEcCtD
Meropenem—Headache—Etoposide—prostate cancer	0.000203	0.000203	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—prostate cancer	0.000203	0.000203	CcSEcCtD
Meropenem—Tension—Doxorubicin—prostate cancer	0.000202	0.000202	CcSEcCtD
Meropenem—Decreased appetite—Prednisone—prostate cancer	0.000202	0.000202	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—prostate cancer	0.000201	0.000201	CcSEcCtD
Meropenem—Malaise—Epirubicin—prostate cancer	0.0002	0.0002	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—prostate cancer	0.0002	0.0002	CcSEcCtD
Meropenem—Syncope—Epirubicin—prostate cancer	0.000199	0.000199	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—prostate cancer	0.000199	0.000199	CcSEcCtD
Meropenem—Back pain—Doxorubicin—prostate cancer	0.000199	0.000199	CcSEcCtD
Meropenem—Constipation—Prednisone—prostate cancer	0.000198	0.000198	CcSEcCtD
Meropenem—Hypersensitivity—Docetaxel—prostate cancer	0.000198	0.000198	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—prostate cancer	0.000195	0.000195	CcSEcCtD
Meropenem—Cough—Epirubicin—prostate cancer	0.000194	0.000194	CcSEcCtD
Meropenem—Asthenia—Docetaxel—prostate cancer	0.000193	0.000193	CcSEcCtD
Meropenem—Nausea—Etoposide—prostate cancer	0.000192	0.000192	CcSEcCtD
Meropenem—Hypertension—Epirubicin—prostate cancer	0.000192	0.000192	CcSEcCtD
Meropenem—Hypersensitivity—Capecitabine—prostate cancer	0.000192	0.000192	CcSEcCtD
Meropenem—Feeling abnormal—Prednisone—prostate cancer	0.000191	0.000191	CcSEcCtD
Meropenem—Pruritus—Docetaxel—prostate cancer	0.00019	0.00019	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—prostate cancer	0.00019	0.00019	CcSEcCtD
Meropenem—Gastrointestinal pain—Prednisone—prostate cancer	0.00019	0.00019	CcSEcCtD
Meropenem—Chest pain—Epirubicin—prostate cancer	0.000189	0.000189	CcSEcCtD
Meropenem—Agitation—Doxorubicin—prostate cancer	0.000189	0.000189	CcSEcCtD
Meropenem—Anxiety—Epirubicin—prostate cancer	0.000189	0.000189	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000188	0.000188	CcSEcCtD
Meropenem—Asthenia—Capecitabine—prostate cancer	0.000187	0.000187	CcSEcCtD
Meropenem—Malaise—Doxorubicin—prostate cancer	0.000186	0.000186	CcSEcCtD
Meropenem—Syncope—Doxorubicin—prostate cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Urticaria—Prednisone—prostate cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Pruritus—Capecitabine—prostate cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—prostate cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Diarrhoea—Docetaxel—prostate cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Body temperature increased—Prednisone—prostate cancer	0.000183	0.000183	CcSEcCtD
Meropenem—Abdominal pain—Prednisone—prostate cancer	0.000183	0.000183	CcSEcCtD
Meropenem—Confusional state—Epirubicin—prostate cancer	0.000183	0.000183	CcSEcCtD
Meropenem—Oedema—Epirubicin—prostate cancer	0.000181	0.000181	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—prostate cancer	0.000181	0.000181	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—prostate cancer	0.000181	0.000181	CcSEcCtD
Meropenem—Infection—Epirubicin—prostate cancer	0.00018	0.00018	CcSEcCtD
Meropenem—Cough—Doxorubicin—prostate cancer	0.00018	0.00018	CcSEcCtD
Meropenem—Shock—Epirubicin—prostate cancer	0.000179	0.000179	CcSEcCtD
Meropenem—Diarrhoea—Capecitabine—prostate cancer	0.000178	0.000178	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—prostate cancer	0.000178	0.000178	CcSEcCtD
Meropenem—Dizziness—Docetaxel—prostate cancer	0.000178	0.000178	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—prostate cancer	0.000178	0.000178	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—prostate cancer	0.000178	0.000178	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—prostate cancer	0.000177	0.000177	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—prostate cancer	0.000176	0.000176	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—prostate cancer	0.000175	0.000175	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—prostate cancer	0.000175	0.000175	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—prostate cancer	0.000175	0.000175	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000174	0.000174	CcSEcCtD
Meropenem—Anorexia—Epirubicin—prostate cancer	0.000173	0.000173	CcSEcCtD
Meropenem—Dizziness—Capecitabine—prostate cancer	0.000172	0.000172	CcSEcCtD
Meropenem—Vomiting—Docetaxel—prostate cancer	0.000171	0.000171	CcSEcCtD
Meropenem—Hypersensitivity—Prednisone—prostate cancer	0.000171	0.000171	CcSEcCtD
Meropenem—Rash—Docetaxel—prostate cancer	0.00017	0.00017	CcSEcCtD
Meropenem—Hypotension—Epirubicin—prostate cancer	0.00017	0.00017	CcSEcCtD
Meropenem—Dermatitis—Docetaxel—prostate cancer	0.000169	0.000169	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—prostate cancer	0.000169	0.000169	CcSEcCtD
Meropenem—Headache—Docetaxel—prostate cancer	0.000169	0.000169	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—prostate cancer	0.000168	0.000168	CcSEcCtD
Meropenem—Oedema—Doxorubicin—prostate cancer	0.000168	0.000168	CcSEcCtD
Meropenem—Infection—Doxorubicin—prostate cancer	0.000167	0.000167	CcSEcCtD
Meropenem—Asthenia—Prednisone—prostate cancer	0.000166	0.000166	CcSEcCtD
Meropenem—Vomiting—Capecitabine—prostate cancer	0.000166	0.000166	CcSEcCtD
Meropenem—Shock—Doxorubicin—prostate cancer	0.000165	0.000165	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—prostate cancer	0.000165	0.000165	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—prostate cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Rash—Capecitabine—prostate cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Pruritus—Prednisone—prostate cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Insomnia—Epirubicin—prostate cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Dermatitis—Capecitabine—prostate cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—prostate cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Headache—Capecitabine—prostate cancer	0.000163	0.000163	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—prostate cancer	0.000163	0.000163	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—prostate cancer	0.000163	0.000163	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—prostate cancer	0.000162	0.000162	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—prostate cancer	0.000162	0.000162	CcSEcCtD
Meropenem—Somnolence—Epirubicin—prostate cancer	0.000161	0.000161	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—prostate cancer	0.00016	0.00016	CcSEcCtD
Meropenem—Nausea—Docetaxel—prostate cancer	0.00016	0.00016	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—prostate cancer	0.00016	0.00016	CcSEcCtD
Meropenem—Diarrhoea—Prednisone—prostate cancer	0.000159	0.000159	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—prostate cancer	0.000158	0.000158	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—prostate cancer	0.000157	0.000157	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000157	0.000157	CcSEcCtD
Meropenem—Pain—Epirubicin—prostate cancer	0.000155	0.000155	CcSEcCtD
Meropenem—Constipation—Epirubicin—prostate cancer	0.000155	0.000155	CcSEcCtD
Meropenem—Nausea—Capecitabine—prostate cancer	0.000155	0.000155	CcSEcCtD
Meropenem—Dizziness—Prednisone—prostate cancer	0.000153	0.000153	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—prostate cancer	0.000152	0.000152	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—prostate cancer	0.000151	0.000151	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—prostate cancer	0.00015	0.00015	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—prostate cancer	0.00015	0.00015	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—prostate cancer	0.000149	0.000149	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—prostate cancer	0.000148	0.000148	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—prostate cancer	0.000148	0.000148	CcSEcCtD
Meropenem—Vomiting—Prednisone—prostate cancer	0.000148	0.000148	CcSEcCtD
Meropenem—Rash—Prednisone—prostate cancer	0.000146	0.000146	CcSEcCtD
Meropenem—Dermatitis—Prednisone—prostate cancer	0.000146	0.000146	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—prostate cancer	0.000146	0.000146	CcSEcCtD
Meropenem—Headache—Prednisone—prostate cancer	0.000145	0.000145	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000145	0.000145	CcSEcCtD
Meropenem—Urticaria—Epirubicin—prostate cancer	0.000144	0.000144	CcSEcCtD
Meropenem—Pain—Doxorubicin—prostate cancer	0.000144	0.000144	CcSEcCtD
Meropenem—Constipation—Doxorubicin—prostate cancer	0.000144	0.000144	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—prostate cancer	0.000143	0.000143	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—prostate cancer	0.000143	0.000143	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—prostate cancer	0.000138	0.000138	CcSEcCtD
Meropenem—Nausea—Prednisone—prostate cancer	0.000138	0.000138	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000137	0.000137	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—prostate cancer	0.000134	0.000134	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—prostate cancer	0.000133	0.000133	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—prostate cancer	0.000133	0.000133	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—prostate cancer	0.000133	0.000133	CcSEcCtD
Meropenem—Asthenia—Epirubicin—prostate cancer	0.00013	0.00013	CcSEcCtD
Meropenem—Pruritus—Epirubicin—prostate cancer	0.000128	0.000128	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—prostate cancer	0.000124	0.000124	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—prostate cancer	0.000124	0.000124	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—prostate cancer	0.00012	0.00012	CcSEcCtD
Meropenem—Dizziness—Epirubicin—prostate cancer	0.00012	0.00012	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—prostate cancer	0.000119	0.000119	CcSEcCtD
Meropenem—Vomiting—Epirubicin—prostate cancer	0.000115	0.000115	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—prostate cancer	0.000115	0.000115	CcSEcCtD
Meropenem—Rash—Epirubicin—prostate cancer	0.000114	0.000114	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—prostate cancer	0.000114	0.000114	CcSEcCtD
Meropenem—Headache—Epirubicin—prostate cancer	0.000114	0.000114	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—prostate cancer	0.000111	0.000111	CcSEcCtD
Meropenem—Nausea—Epirubicin—prostate cancer	0.000108	0.000108	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—prostate cancer	0.000107	0.000107	CcSEcCtD
Meropenem—Rash—Doxorubicin—prostate cancer	0.000106	0.000106	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—prostate cancer	0.000106	0.000106	CcSEcCtD
Meropenem—Headache—Doxorubicin—prostate cancer	0.000105	0.000105	CcSEcCtD
Meropenem—Nausea—Doxorubicin—prostate cancer	9.97e-05	9.97e-05	CcSEcCtD
